Health In Tech to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025
Event: Health In Tech's 2024 Fourth Quarter and Full Year Earnings Conference Call
When: Monday, March 17, 2025, at 5:00 p.m. ET
Live Call:
PARTICIPANT DIAL IN (TOLL FREE): 1-888-346-8982PARTICIPANT INTERNATIONAL DIAL IN: 1-412-902-4272Hong Kong Toll Free: 800-905945Hong Kong-Local Toll: 852-301-84992
Webcast Link:https://event.choruscall.com/mediaframe/webcast.html?webcastid=D0BJw8tJ
Replay: A webcast replay will be available on Health In Tech's investor relations website at https://healthintech.investorroom.com/ shortly after the completion of the call, and will remain available for approximately 90 day.
About Health In Tech
Health In Tech (Nasdaq: HIT) is an Insurtech platform company backed by third-party AI technology, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs. Learn more at healthintech.com.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.
Investor Contact
Investor Relations:ir@healthintech.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-march-17-2025-302395910.html
SOURCE Health In Tech
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Why AppLovin Stock Was Gaining Today
Key Points Meta's revenue grew 22% in the second quarter, reflecting strong ad demand. That and Microsoft's strong quarter could bode well for AppLovin, as the high-growth stock is set to report Q2 earnings next week. Analysts are expecting earnings per share to double to $2.32. 10 stocks we like better than AppLovin › Shares of AppLovin (NASDAQ: APP), the fast-growing adtech company, were soaring today even as there was no news out on the company. Instead, the stock seemed to benefit from a wave of bullish sentiment for artificial intelligence (AI) and digital advertising stocks after strong reports from both Meta Platforms and Microsoft last night. As a result, AppLovin stock was up 8.2% as of 12:53 p.m. ET, while those two big tech stocks gained as well. AppLovin rides Meta's coattails Strong results from Meta in particular seemed to benefit AppLovin, as Meta's report showed off healthy demand in the digital advertising market. Revenue jumped 22% to $47.5 billion, and advertising made up 98% of its revenue, showing strong demand for ads on Facebook and Instagram. Meta credited AI improvements for driving both growth in ad impressions and an increase in the price per ad, reflecting increased demand and ROI. That trend, along with Microsoft's strong quarterly numbers, set off a wave of bullishness for stocks like AppLovin, which is high-priced and high-growth and offers exposure to both adtech and AI. In fact, AppLovin may be ahead of the curve in AI-driven advertising, as its AI-powered recommendation engine, Axon, has been a key source of growth for the company recently. What's next for AppLovin? As an expensive, high-growth stock, AppLovin tends to be volatile, and today's gains reflect an improved perception of its future growth ahead of its own earnings report on Aug. 6. Investors are expecting 13% revenue growth to $1.22 billion in the quarter, though that includes the sale of its mobile apps business. Excluding that, organic growth will be much stronger. On the bottom line, analysts expect earnings per share to essentially double to $2.32, a better reflection of the underlying growth in the business. The stock has the potential to pop again if it can beat those estimates. Do the experts think AppLovin is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did AppLovin make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,049% vs. just 182% for the S&P — that is beating the market by 867.25%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $638,629!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,098,838!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Jeremy Bowman has positions in AppLovin and Meta Platforms. The Motley Fool has positions in and recommends AppLovin, Meta Platforms, and Microsoft. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. Why AppLovin Stock Was Gaining Today was originally published by The Motley Fool 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
Yahoo
an hour ago
- Yahoo
Apple (AAPL) Poised for Major Cash Windfall Thanks to Big Beautiful Bill
Apple Inc. (NASDAQ:AAPL) is one of the . On July 30, Morgan Stanley reiterated the stock as 'Overweight.' According to the firm, One Big Beautiful Bill Act (OBBBA) will offer a significant boost to free cash flow (FCF) across the IT hardware sector. It noted that Apple is one of the big beneficiaries of the Big Beautiful bill. 'We estimate the One Big Beautiful Bill Act (OBBBA) can add 12% upside to our IT Hardware coverage FCF in 2025, and 5%, on average, annually, to our coverage over the next 4 years,' Through the bill, companies will be able to immediately deduct R&D and capital investment expenses from U.S. taxes. This will accelerate their tax savings and increase near-term cash flow. 'We estimate that over the next 4 years, the [One Big Beautiful Bill] will add a cumulative $20.3B of upside to our AAPL [free-cash flow] forecast, all else equal, which equates to an average annual FCF tailwind of 4%.' The firm projects the legislation will generate more than $12 billion in incremental cash flow for covered names over the next year, as well as $20 billion cumulatively over four years. 'This benefit is mostly about timing, as it pulls forward future tax savings rather than changing the long-term cash flow picture,' the analysts said. Apple is a technology company known for its consumer electronics, software, and services. While we acknowledge the potential of AAPL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Must-Watch AI Stocks on Wall Street and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Marvell (MRVL) Remains in AI Winners Camp as Morgan Stanley Nudges Target Higher
Marvell Technology, Inc. (NASDAQ:MRVL) is one of the . On July 30, Morgan Stanley analyst Joseph Moore raised the price target on the stock to $80.00 (from $73.00) while maintaining an 'Equal Weight' rating. 'Marvell is firmly in the AI winners camp, and sentiment has swung aggressively negative compared to a few months ago,' Moore wrote. 'We are more excited for their opportunity in optical, which brings higher margin and durability vs. their ASIC opportunity, which has disappointed.' An analyst studying a graph of a company's asset value and potential cash flow. Moore expects Marvell to benefit from strong AI demand in the coming year. 'While stock prices have moved higher, our conviction on AI spend durability in 2026 continues to grow.' Marvell Technology, Inc. (NASDAQ:MRVL) engages in the development and production of semiconductors, focusing heavily on data centers. While we acknowledge the potential of MRVL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Must-Watch AI Stocks on Wall Street and Disclosure: None.
